GnRH analogue (GnRH-a) administration induces a significant reduction of cognitive functions in premenopausal women with symptomatic uterine leiomyomas and, notwithstanding the appearance of climacteric-like symptoms, the effectiveness of analogue induces a significant improvement of mood and quality of life. The addition of raloxifene to GnRH-a treatment has no clinical effect on cognition, mood, and quality of life in this sample of women.

Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life / Palomba, S; Orio, F Jr; Russo, T; Falbo, A; Amati, A; Zullo, F.. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - 82:2(2004), pp. 480-482. [10.1016/j.fertnstert.2003.11.061]

Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life

Palomba S;
2004

Abstract

GnRH analogue (GnRH-a) administration induces a significant reduction of cognitive functions in premenopausal women with symptomatic uterine leiomyomas and, notwithstanding the appearance of climacteric-like symptoms, the effectiveness of analogue induces a significant improvement of mood and quality of life. The addition of raloxifene to GnRH-a treatment has no clinical effect on cognition, mood, and quality of life in this sample of women.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1653682
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 16
social impact